CD24 and breast carcinoma: To isolate BCSCs, we used specific antibodies against surface markers (CD44, CD24 or Epithelial Cell Adhesion Molecule (ESA) in a luminal (MCF7) and a triple negative (MDA-MB-231) breast cancer cell line.